Bacterial contamination of blood components is a long-standing problem affecting the safety of blood supply. Transfusiontransmitted syphilis was the first recognized bacterial infection transmitted by blood transfusions via vascular anastomosis, first described in 1915 and successfully eliminated mainly by reducing the frequency of infection and by donor screening [1] . The first fatality due to whole blood transfusion was reported in 1942 [2] .
In the past decades remarkable advances could be achieved in all fields of work in blood establishments that improved quality and safety of blood components. Most efforts were concentrated on minimizing the risk of transfusion-transmitted virus infections. Meanwhile the residual bacterial risk for transfusion-transmitted infections has become the most frequent infection risk in transfusion medicine.
In the past 15 years many studies focused on the challenge of bacterial contaminations, especially of platelet concentrates (PCs). Numerous measures were implemented to reduce the initial contamination of blood at the time of collection and to reduce bacteria proliferation during processing and storage of blood components. The cumulative effect of these measures led to a significant improvement, but hemovigilance systems internationally still report cases of serious morbidity and mortality due to bacterial contaminations [3] [4] [5] .
As reported in hemovigilance systems the risks of bacterial contamination of platelets are currently the major infection risk. Low numbers of bacteria may initially contaminate PCs, but storage at 22 °C for several days allows growth followed by high bacterial loads at the time of transfusion. Culturebased pre-release screening of PCs with early sampling has proven to detect bacteria and to prevent transfusion of some but not all contaminated units. In a study of one million apheresis PCs the rate of septic reactions decreased from 18 to 5.4 reactions per million transfused units, but the fatality rate did not decrease [6] . Fatalities were not associated with bacteria typical for skin flora but with Gram-negative rods, mainly Enterobacteriaceae. The risk of severe and fatal reactions, particularly with these more virulent contaminants, is therefore likely to remain. Most studies on results of prerelease screening of platelets with early sampling (within 24 h after blood donation) reported septic reactions due to falsenegative cultures. Based on the reported data it can be suggested that bacterial culture may fail to detect more than half of the contaminated products [7] . As risk of severe reactions increases with the age of PCs, the Advisory Board of the German Ministry of Health decided in 2008 to reduced the maximum shelf life for PCs from 5 days after donation to 4 days [8] .
Rapid detection methods with a late sample collection (day 3, day 4 or day 5 after donation) are suitable for testing platelets for bacteria prior to issue for transfusion. Some tests are already available, others are in development; but much work remains to optimize tests for routine use and to find out when they give most useful results.
As French hemovigilance data show, bacterial contamination of red blood cell (RBC) concentrates accounts for 10% or less of severe septic reactions; measures implemented to improve bacterial safety reduced the frequency of transfusion reactions caused by contaminated RBC concentrates [9] . In Germany the absolute number of reported septic reactions associated with transfusion of RBC concentrates and PCs in the observation period 1997-2008 is in the same range, with 34-38 reports [5] . In that time frame, 20.6 million RBC concentrates and 4.2 million PCs were transfused. Thus the ideal strategy to improve bacterial safety should include all blood components.
Pathogen inactivation, an approach that purposes a fundamentally different and far more ambitious objective, focuses on viruses, parasites, leukocytes and bacteria as contaminants of blood components. Inactivation techniques that optimally preserve the biological function of constituents and are harmless to the recipient are under evaluation for their efficacy and Walther-Wenke/Schmidt ture methods in combination with the 'negative-to-date' concept, rapid detection systems with a late sampling and bedside screening tests. Each system exhibits advantages and disadvantages and offers only a temporary solution until a general pathogen inactivation technology is available for all blood components.
de Korte [15] describes the Dutch experience with 10 years bacterial screening of platelets with the BacT/ALERT culturing system using a high inoculation volume and release of products on a 'negative-to-date' basis. In the Netherlands platelets have a maximum shelf life of 7 days since 2002. The author states, that the number of transfusion-transmitted bacterial infections currently is very low.
Borosak and Wood [16] give a report about the Australian experience where bacterial screening of platelets was implemented in April 2008. Authors state that screening of platelets is an important improvement in transfusion safety.
Müller et al. [17] describe the specific threats of bacteria as contaminants of blood components and their impact on the assessment of the effectiveness of pathogen reduction procedures. Studies were done with internationally accepted bacterial standards, developed by the Paul-Ehrlich-Institute, which enable a better comparison with different study designs.
All together this issue of TRANSFUSION MEDICINE AND HEMOTHERAPY provides an overview on different aspects of bacterial contaminations of blood components and challenges, issues and difficulties to improve blood safety. safety. They promise to be a solution for the difficult problem of bacterial contamination in the future.
The current issue of TRANSFUSION MEDICINE AND HEMO-THERAPY is focused on impact of bacterial contamination on blood supply. Walther-Wenke et al. [10] present data on bacterial contamination rates of blood components that origin from routine quality control investigations in German blood establishments. Data out of three surveys between 1998 and 2006 show a remarkable decline in bacterial contamination rates of all blood components as a result of safety measures implemented in donation and manufacturing processes.
McDonald [11] focuses on interventions such as improved donor arm disinfection and diversion of the initial blood flow and describes their impact on the bacterial contamination rate. Data from a National Health Service Blood and Transplant study indicate a reduction of the bacterial contamination rate of blood components by about 70%.
Funk et al. [12] report German hemovigilance data on transfusion-transmitted bacteria infections that were collected from 1997 to 2010, and analyze the incidence of transfusiontransmitted bacteria infections before and after implementation of risk-reducing measures.
Gatermann [13] describes bacteria species known as contaminants of blood components with respect to their pathogenicity.
Schmidt et al. [14] present an overview of bacterial detection methods which can be clustered into three groups: cul-
